EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

cholesteryl butyrate
cholest-5-en-3b-ol butyrate

Supplier Sponsors

Name:[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] butanoate
CAS Number: 521-13-1Picture of molecule3D/inchi
ECHA EINECS - REACH Pre-Reg:208-304-7
FDA UNII: 50QA4YCP7F
Nikkaji Web:J60.879C
MDL:MFCD00021144
XlogP3-AA:9.90 (est)
Molecular Weight:456.75384000
Formula:C31 H52 O2
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:cosmetic ingredient for skin conditioning
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Boiling Point: 518.00 °C. @ 760.00 mm Hg (est)
Flash Point: 508.00 °F. TCC ( 264.30 °C. ) (est)
logP (o/w): 11.770 (est)
Soluble in:
 water, 9.339e-007 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
CosIng:cosmetic data
Cosmetic Uses: skin conditioning
 
Suppliers:
Santa Cruz Biotechnology
For experimental / research use only.
Cholesteryl Butyrate
Sigma-Aldrich: Sigma
For experimental / research use only.
Cholesteryl Butyrate ∼95%
TCI AMERICA
For experimental / research use only.
Cholesterol Butyrate
 
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
cosmetic ingredient for skin conditioning
Recommendation for cholesteryl butyrate usage levels up to:
 not for fragrance use.
 
Recommendation for cholesteryl butyrate flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):521-13-1
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :101741
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] butanoate
Chemidplus:0000521131
 
References:
 [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] butanoate
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:521-13-1
Pubchem (cid):101741
Pubchem (sid):135059775
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):Search
Export Tariff Code:2937.29.9090
ChemSpider:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
 butanoic acid, (3b)-cholest-5-en-3-yl ester
 butyric acid cholesteryl ester
 cholest-5-en-3b-ol butyrate
 cholest-5-en-3beta-ol butyrate
5-cholesten-3b-ol 3-butyrate
 cholesterol butyrate
 cholesteryl butanoate
 cholesteryl N-butyrate
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] butanoate
3b-hydroxy-5-cholestene 3-butyrate
 

Articles:

PubMed:Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
PubMed:Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.
PubMed:Influence of supercritical CO(2) pressurization on the phase behavior of mixed cholesteryl esters.
PubMed:Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model.
PubMed:Application of comprehensive two-dimensional gas chromatography to sterols analysis.
PubMed:Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.
PubMed:Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?
PubMed:Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.
PubMed:Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
PubMed:Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.
PubMed:In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
PubMed:The effect of formulation and concentration of cholesteryl butyrate solid lipid nanospheres (SLN) on NIH-H460 cell proliferation.
PubMed:Fatty acid steryl, stanyl, and steroid esters by esterification and transesterification in vacuo using Candida rugosa lipase as catalyst.
PubMed:Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery.
PubMed:Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters.
PubMed:Use of the minimal function for partial structure development in direct methods.
PubMed:Crystal structure of cholesteryl butanoate at 123 K.
PubMed:Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis.
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy